Conference Coverage
S5-E17 – Previewing EASL Congress 2024 & Its Major MASLD Moments
EASL Secretary General Aleksander Krag and our other guests, Hannes Hagstrom and Michelle Long, join Jörn Schattenberg and Roger Green to discuss MASLD-related highlights of EASL Congress 2024.
S5-E16.5 – From the Vault: Stephen Harrison Discusses FASCINATE-2 Results for Denifenstat
This week’s vault episode offers the last time Stephen Harrison presented results of a specific drug trial on the podcast.
S5-06 – Rezdiffra Is Here! Key Opinion Leaders React to the First MASH Drug Approval
Last Thursday, FDA approved Rezdiffra, the first MASH drug! A global panel of key opinion leaders joins the Surfers to share excitement and discuss the implications of this landmark event.
S5-3.06 – From the Vault: EASL Congress 2023: Focus on the New MASLD Nomenclature
This conversation reviews several other topics related to the new MASLD nomenclature: impact on NITs and ICD codes, future vision for MASH, and general satisfaction with the process to date.
S5-3.05 – The New MASLD Nomenclature: What Lies Ahead For MASH Patients and Providers?
This conversation reviews several other topics related to the new MASLD nomenclature: impact on NITs and ICD codes, future vision for MASH, and general satisfaction with the process to date.
S5-3.04 – Discussing MASLD with Patients: MASH Is Not “Just a Little Fat” Any More
This conversation focuses on ways the new MASLD Nomenclature can improve the ways providers explain MASH to patients.
S5-3.02 – How did the Delphi Process Work for the New MASLD Nomenclature?
In this discussion, Jeff Lazarus, who oversaw the global Delphi process that led to the final new MASLD nomenclature, describe how a Delphi process works and some of its strengths and weaknesses here.
S5-03.1 – Why Create a New MASLD Nomenclature?
In this discussion, Maru Rinella, who co-led the new MASLD nomenclature process, and Jeff Lazarus, who oversaw a large Delphi process that led to the final result, describe how the process came to be.
S4-E44.4 – How does MASH and MASLD differ in women compared to men?
This final conversation covers the other paper discussed in the episoe at large, a literature review looking at how MASH and MASLD might differ in women compared to men. Roberta starts by noting the gap in literature about gender differences in MASH studies, and that women appear represented in most clinical trials.
S4-E42.6 – From the Vault: NAFLD Summit in Context and Learning from Failed Trials
This episode From the Vault comes from last year’s SurfingNASH review of the 2022 NAFLD Summit with Mazen Noureddin, Sven Francque and Hannes Hagström.
The 2022 NAFLD Summit uniquely presented a range of perspectives and insights on fatty liver and metabolic diseases.
S4-E42.5 – Final Recap of the 2023 SLD Summit: Takeaways and Looking Forward
The EASL SLD Summit aims at updating a global community of liver stakeholders on the most recent advances in SLD research, both pre-clinically and clinically, focusing on MASLD and tackling the issue of MetALD. In this episode, Jörn Schattenberg, Louise Campbell and Roger Green review the recently concluded meeting with faculty members Sven Francque and Hannes Hagström in two seperate interviews.
S4-E42.3 – Diving into Research from the EASL SLD Summit
The EASL SLD Summit aims at updating a global community of liver stakeholders on the most recent advances in SLD research, both pre-clinically and clinically, focusing on MASLD and tackling the issue of MetALD.
In this episode, Jörn Schattenberg, Louise Campbell and Roger Green review the recently concluded meeting with faculty members Sven Francque and Hannes Hagström in two seperate interviews.
S4-E42.2 – MASH, MetALD and Alcoholic SLD: A Continuum?
The EASL SLD Summit aims at updating a global community of liver stakeholders on the most recent advances in SLD research, both pre-clinically and clinically, focusing on MASLD and tackling the issue of MetALD.
In this episode, Jörn Schattenberg, Louise Campbell and Roger Green review the recently concluded meeting with faculty members Sven Francque and Hannes Hagström in two seperate interviews.
S4-E42.1 – Sven Francque on Organizing the EASL SLD Summit
The EASL SLD Summit aims at updating a global community of liver stakeholders on the most recent advances in SLD research, both pre-clinically and clinically, focusing on MASLD and tackling the issue of MetALD.
In this episode, Jörn Schattenberg, Louise Campbell and Roger Green review the recently concluded meeting with faculty members Sven Francque and Hannes Hagström in two seperate interviews.
S4-31 – Mazen Noureddin and Jörn Schattenberg on the Developing Therapeutic Landscape
Roger Green speaks with Mazen Noureddin and Jörn Schattenberg to discuss key findings and issues emerging from the recent EASL Congress and American Diabetes Association Scientific Sessions.
S5-E24 – A View of MASLD: Looking Back at EASL Congress From Six Weeks Later
PharmaNest Founder and CEO Mathieu Petitjean and Global LIver Institute Vice President of Liver Programs Jeff McIntyre join Roger Green for 1:1 interviews exploring their key takeaways and strategic shifts resulting from the EASL Congress 2024, followed by a review of answers to a previous Question of the Week.
S5-E23.4 – From the EASL Congress: Socioeconomic And Psychological Issues In The Physician-Patient Dialogue
Four panelists from the EASL Congress session on “Patient Experiences in Clinical Settings” join Louise Campbell to how socioeconomic and psychological issues can affect the physician-patient dialogue.
S5-E23.3 – From the EASL Congress: Improving the Physician-Patient Dialogue
Four panelists from the EASL Congress session on “Patient Experiences in Clinical Settings” join Louise Campbell to discuss ways to improve information sharing in the physician-patient dialogue.
S5-E23.2 – From the EASL Congress: Dynamics of the Physician-Patient Dialogue
Four panelists from the EASL Congress session on “Patient Experiences in Clinical Settings” join Louise Campbell to discuss some dynamics of the physician-patient dialogue.
S5-E23.1 – From the EASL Congress: Overview of Challenges in Physician-Patient Communication
This conversation with Louise Campbell and four panelists from the EASL Congress session titled “Patient Experiences in Clinical Settings” provides an overview of issues in physician-patient communication.
S5-E23 – Lessons from EASL Congress: Challenges in Provider-Patient Communication
Louise Campbell leads a discussion about challenges in provider-patient communication with Shira Zelber-Sagi and Mike Betel, who chaired a session on this topic at the EASL Congress 2024, and Tom Marjot and Jose Willemse, who were panelists for the discussion.